Breaking News Instant updates and real-time market news.

AAPL

Apple

$266.05 /

+6.55 (+2.52%)

06:42
04/09/20
04/09
06:42
04/09/20
06:42

Apple price target raised to $240 from $225 at Nomura Instinet

Nomura Instinet analyst Jeffrey Kvaal raised the firm's price target on Apple to $240 from $225 and keeps a Neutral rating on the shares. The Apple bull thesis, built upon a "robust" ecosystem, multiple expansion and a strong balance sheet, "holds merit," Kvaal tells investors in a research note. However, a looming recession and "inflated supercycle expectations" undermine the bull case, adds the analyst. He believes Apple's 5G rollout is not enough to overlook the looming recession.

  • 30

    Apr

AAPL Apple
$266.05 /

+6.55 (+2.52%)

04/08/20 Wedbush
Wedbush now assumes Apple's 5G iPhones don't get released this fall
04/08/20 JPMorgan
Apple price target lowered to $335 from $350 at JPMorgan
04/08/20 Piper Sandler
Apple price target raised to $300 from $260 at Piper Sandler
04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens

TODAY'S FREE FLY STORIES

Recommendations
Charles River price target raised to $190 from $150 at Argus » 08:40
05/26/20
05/26
08:40
05/26/20
08:40
CRL

Charles River

$173.32 /

-2.21 (-1.26%)

Argus analyst David Toung…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRL Charles River
$173.32 /

-2.21 (-1.26%)

CRL Charles River
$173.32 /

-2.21 (-1.26%)

05/13/20 UBS
Charles River upgraded to Buy from Neutral at UBS
05/08/20 Baird
Charles River price target raised to $175 from $156 at Baird
05/08/20 SunTrust
Charles River price target raised to $194 from $130 at SunTrust
04/21/20 Jefferies
Jefferies downgrades Charles River to Hold after 51% rally from lows
CRL Charles River
$173.32 /

-2.21 (-1.26%)

General news
FX Action: USD-JPY » 08:40
05/26/20
05/26
08:40
05/26/20
08:40

FX Action: USD-JPY…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Cerus submits PMA-S for pathogen reduced cryoprecipitated fibrinogen complex » 08:40
05/26/20
05/26
08:40
05/26/20
08:40
CERS

Cerus

$5.92 /

+0.36 (+6.47%)

Cerus announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERS Cerus
$5.92 /

+0.36 (+6.47%)

CERS Cerus
$5.92 /

+0.36 (+6.47%)

02/26/20 BTIG
Cerus initiated with a Buy at BTIG
01/23/20 Cowen
Cowen encouraged by Cerus data on Intercept in light of new coronavirus
11/13/19 BTIG
Cerus upgraded to Buy from Neutral at BTIG
08/28/19
Fly Intel: Top five analyst initiations
CERS Cerus
$5.92 /

+0.36 (+6.47%)

CERS Cerus
$5.92 /

+0.36 (+6.47%)

Hot Stocks
Aeglea BioTherapeutics announces one-year data for pegzilarginase » 08:39
05/26/20
05/26
08:39
05/26/20
08:39
AGLE

Aeglea BioTherapeutics

$8.86 /

+0.2 (+2.31%)

Aeglea BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGLE Aeglea BioTherapeutics
$8.86 /

+0.2 (+2.31%)

AGLE Aeglea BioTherapeutics
$8.86 /

+0.2 (+2.31%)

05/04/20
Fly Intel: Top five analyst initiations
05/04/20 Piper Sandler
Aeglea BioTherapeutics initiated with an Overweight at Piper Sandler
04/30/20 H.C. Wainwright
Aeglea BioTherapeutics price target lowered to $18 from $24 at H.C. Wainwright
02/25/20 H.C. Wainwright
Aeglea BioTherapeutics price target raised to $24 from $20 at H.C. Wainwright
AGLE Aeglea BioTherapeutics
$8.86 /

+0.2 (+2.31%)

Downgrade
Scotts Miracle-Gro double downgraded to Market Perform Raymond James » 08:39
05/26/20
05/26
08:39
05/26/20
08:39
SMG

Scotts Miracle-Gro

$150.10 /

+1 (+0.67%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMG Scotts Miracle-Gro
$150.10 /

+1 (+0.67%)

SMG Scotts Miracle-Gro
$150.10 /

+1 (+0.67%)

04:43 Today Raymond James
Scotts Miracle-Gro downgraded to Market Perform from Strong Buy at Raymond James
05/14/20 SunTrust
Scotts Miracle-Gro, Central Garden & Pet price targets raised at SunTrust
05/07/20 SunTrust
Scotts Miracle-Gro price target raised to $140 from $115 at SunTrust
03/30/20 BofA
US 1 List changes at BofA
SMG Scotts Miracle-Gro
$150.10 /

+1 (+0.67%)

Hot Stocks
Sky Solar announces receipt of preliminary non-binding proposal » 08:37
05/26/20
05/26
08:37
05/26/20
08:37
SKYS

Sky Solar

$3.30 /

-0.09 (-2.65%)

Sky Solar Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKYS Sky Solar
$3.30 /

-0.09 (-2.65%)

Syndicate
TransMedics announces proposed public offering of common stock » 08:36
05/26/20
05/26
08:36
05/26/20
08:36
TMDX

TransMedics

$16.01 /

+0.55 (+3.56%)

TransMedics Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

04/06/20 Oppenheimer
Oppenheimer starts TransMedics with Outperform, $25 price target
04/06/20 Oppenheimer
TransMedics initiated with an Outperform at Oppenheimer
11/07/19 Cowen
TransMedics price target lowered to $28 from $40 at Cowen
10/07/19 Cowen
TransMedics weakness a buying opportunity, says Cowen
TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

TMDX TransMedics
$16.01 /

+0.55 (+3.56%)

Hot Stocks
Durect announces results from Phase 1b clinical study of DUR-928 » 08:36
05/26/20
05/26
08:36
05/26/20
08:36
DRRX

Durect

$2.47 /

-0.06 (-2.37%)

DURECT announced positive…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

05/12/20 Cantor Fitzgerald
Durect risk/reward 'highly favorable' into Posimir decision, says Cantor
03/04/20 Cantor Fitzgerald
Cantor reiterates Overweight on Durect with $5 target post results
01/31/20 B. Riley FBR
B. Riley FBR starts Durect with Buy rating, $5 price target
01/31/20 B. Riley FBR
Durect initiated with a Buy at B. Riley FBR
DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

DRRX Durect
$2.47 /

-0.06 (-2.37%)

Syndicate
Viela Bio announces proposed offering of common stock » 08:35
05/26/20
05/26
08:35
05/26/20
08:35
VIE

Viela Bio

$60.14 /

+0.755 (+1.27%)

Viela Bio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

05/14/20 Guggenheim
Viela Bio price target raised to $78 from $51 at Guggenheim
05/14/20 H.C. Wainwright
Viela Bio price target raised to $70 from $60 at H.C. Wainwright
04/29/20
Fly Intel: Top five analyst initiations
04/29/20 Wedbush
Wedbush bullish on Viela Bio, initiates with an Outperform
VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

VIE Viela Bio
$60.14 /

+0.755 (+1.27%)

Hot Stocks
Beyond Air receives approval from Health Canada to study nitric oxide » 08:35
05/26/20
05/26
08:35
05/26/20
08:35
XAIR

Beyond Air

$8.06 /

-0.2 (-2.42%)

Beyond Air announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XAIR Beyond Air
$8.06 /

-0.2 (-2.42%)

XAIR Beyond Air
$8.06 /

-0.2 (-2.42%)

10/21/19 Oppenheimer
Oppenheimer starts Beyond Air with Outperform rating, $9 price target
10/21/19 Oppenheimer
Beyond Air initiated with an Outperform at Oppenheimer
XAIR Beyond Air
$8.06 /

-0.2 (-2.42%)

General news
Chicago Fed National Activity Index 3 Month Moving Average data reported » 08:35
05/26/20
05/26
08:35
05/26/20
08:35

April Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Chicago Fed National Activity Index Level data reported » 08:35
05/26/20
05/26
08:35
05/26/20
08:35

April Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Cirrus Logic price target raised to $82 from $80 at Stifel » 08:33
05/26/20
05/26
08:33
05/26/20
08:33
CRUS

Cirrus Logic

$73.40 /

+0.09 (+0.12%)

, AAPL

Apple

$318.75 /

+1.83 (+0.58%)

Stifel analyst Tore…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

05/05/20 Susquehanna
Cirrus Logic price target raised to $84 from $82 at Susquehanna
05/04/20 KeyBanc
Apple cautious iPhone outlook likely a headwind for chip suppliers, says KeyBanc
03/31/20
upgraded Fly Intel: Top five analyst upgrades
03/31/20 BofA
Cirrus Logic double-upgraded to Buy from Underperform at BofA
AAPL Apple
$318.75 /

+1.83 (+0.58%)

08:14 Today Cowen
Apple checks suggest four new iPhones this year, says Cowen
05/18/20 Wedbush
Apple yet again caught in U.S./China Tensions, says Wedbush
05/12/20 Wedbush
Apple price target raised to $350 from $335 at Wedbush
05/07/20 Bernstein
Google payments to Apple big, predicated on advertising, says Bernstein
CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

CRUS Cirrus Logic
$73.40 /

+0.09 (+0.12%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

AAPL Apple
$318.75 /

+1.83 (+0.58%)

Hot Stocks
Auris Medical announces data from AM-201 Phase 1b study » 08:33
05/26/20
05/26
08:33
05/26/20
08:33
EARS

Auris Medical

$1.10 /

+ (+0.00%)

Auris Medical Holding…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EARS Auris Medical
$1.10 /

+ (+0.00%)

EARS Auris Medical
$1.10 /

+ (+0.00%)

Hot Stocks
NeuroBo receives notice from FDA regarding development program for Gemcabene » 08:32
05/26/20
05/26
08:32
05/26/20
08:32
NRBO

NeuroBo Pharmaceuticals

$13.53 /

-0.32 (-2.31%)

NeuroBo Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRBO NeuroBo Pharmaceuticals
$13.53 /

-0.32 (-2.31%)

NRBO NeuroBo Pharmaceuticals
$13.53 /

-0.32 (-2.31%)

02/18/20 Ladenburg
NeuroBo Pharmaceuticals initiated with a Buy at Ladenburg
NRBO NeuroBo Pharmaceuticals
$13.53 /

-0.32 (-2.31%)

Recommendations
Synnex price target raised to $115 from $96 at Barrington » 08:32
05/26/20
05/26
08:32
05/26/20
08:32
SNX

Synnex

$100.23 /

-0.92 (-0.91%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNX Synnex
$100.23 /

-0.92 (-0.91%)

SNX Synnex
$100.23 /

-0.92 (-0.91%)

04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
03/25/20 Barrington
Synnex price target lowered to $96 from $150 at Barrington
03/25/20 Cross Research
Synnex downgraded to Hold from Buy at Cross Research
03/25/20 Raymond James
Synnex price target lowered to $120 from $165 at Raymond James
SNX Synnex
$100.23 /

-0.92 (-0.91%)

SNX Synnex
$100.23 /

-0.92 (-0.91%)

SNX Synnex
$100.23 /

-0.92 (-0.91%)

Hot Stocks
Arena Pharmaceuticals completes full enrollment in Phase 2 ADVISE trial » 08:32
05/26/20
05/26
08:32
05/26/20
08:32
ARNA

Arena Pharmaceuticals

$58.93 /

+1.51 (+2.63%)

Arena Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
05/18/20 Jefferies
Arena Pharmaceuticals initiated with a Buy at Jefferies
03/31/20 Guggenheim
Guggenheim starts Arena at Buy on 'pipeline-in-a-product' etrasimod
ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

ARNA Arena Pharmaceuticals
$58.93 /

+1.51 (+2.63%)

Hot Stocks
Protara Therapeutics receives Fast Track designation for IV Choline Chloride » 08:31
05/26/20
05/26
08:31
05/26/20
08:31
TARA

Protara Therapeutics

$40.55 /

+5.05 (+14.23%)

Protara Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TARA Protara Therapeutics
$40.55 /

+5.05 (+14.23%)

TARA Protara Therapeutics
$40.55 /

+5.05 (+14.23%)

01/22/20 Ladenburg
ArTara Therapeutics initiated with a Buy at Ladenburg
TARA Protara Therapeutics
$40.55 /

+5.05 (+14.23%)

Upgrade
Ollie's Bargain Outlet upgraded to Buy at Craig-Hallum » 08:31
05/26/20
05/26
08:31
05/26/20
08:31
OLLI

Ollie's Bargain Outlet

$85.55 /

+2.07 (+2.48%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

07:22 Today Craig-Hallum
Ollie's Bargain Outlet upgraded to Buy from Hold at Craig-Hallum
06:04 Today Credit Suisse
Ollie's Bargain Outlet downgraded to Neutral from Outperform at Credit Suisse
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 KeyBanc
Ollie's Bargain Outlet price target raised to $80 from $74 at KeyBanc
OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

OLLI Ollie's Bargain Outlet
$85.55 /

+2.07 (+2.48%)

Options
One option delisting on May 26th » 08:30
05/26/20
05/26
08:30
05/26/20
08:30

Option delistings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Splunk price target raised to $215 from $156 at Argus » 08:28
05/26/20
05/26
08:28
05/26/20
08:28
SPLK

Splunk

$184.37 /

+21.1 (+12.92%)

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

05/22/20 JMP Securities
Splunk price target raised to $200 from $155 at JMP Securities
05/22/20 JPMorgan
Splunk price target raised to $190 from $174 at JPMorgan
05/22/20 Raymond James
Splunk price target raised to $185 from $140 at Raymond James
05/22/20 Oppenheimer
Splunk price target raised to $190 from $145 at Oppenheimer
SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

SPLK Splunk
$184.37 /

+21.1 (+12.92%)

Conference/Events
Evofem to hold a pharmaceutical update conference call » 08:25
05/26/20
05/26
08:25
05/26/20
08:25
EVFM

Evofem

$4.98 /

+0.18 (+3.75%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

EVFM Evofem
$4.98 /

+0.18 (+3.75%)

04/16/20 Roth Capital
Roth believes Evofem 'underappreciated' ahead of Phexxi PDUFA date
12/18/19 Roth Capital
Evofem's Amphora getting closer to FDA approval, says Roth Capital
12/11/19 H.C. Wainwright
Evofem price target raised to $11 from $9 at H.C. Wainwright
10/16/19 Cantor Fitzgerald
Evofem assumed with an Overweight at Cantor Fitzgerald
EVFM Evofem
$4.98 /

+0.18 (+3.75%)

Syndicate
Caladrius announces $4.3M registered direct offering priced at-the-market » 08:24
05/26/20
05/26
08:24
05/26/20
08:24
CLBS

Caladrius

$2.08 /

+0.16 (+8.33%)

Caladrius Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

05/22/20 Brookline
Caladrius initiated with a Buy at Brookline
05/18/20 Dawson James
Caladrius downgraded to Neutral from Buy at Dawson James
CLBS Caladrius
$2.08 /

+0.16 (+8.33%)

Recommendations
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink » 08:24
05/26/20
05/26
08:24
05/26/20
08:24
REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

, SNY

Sanofi

$47.31 /

-0.18 (-0.38%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

06:29 Today Wells Fargo
Regeneron upgraded to Overweight at Wells Fargo on EYLEA Survey
04:44 Today Wells Fargo
Regeneron upgraded to Overweight from Equal Weight at Wells Fargo
05/19/20 Roth Capital
Rapt CCR4 antagonist may be competitive against Dupixent, says Roth Capital
05/15/20 Piper Sandler
Ocular Therapeutix early OTX-TKI data encouraging, says Piper Sandler
SNY Sanofi
$47.31 /

-0.18 (-0.38%)

05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
05/06/20 Oppenheimer
Regeneron price target raised to $625 from $525 at Oppenheimer
04/30/20 Roth Capital
aTyr Pharma '1923 another 'shot on goal' in COVID-19 fight, says Roth Capital
04/28/20 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

SNY Sanofi
$47.31 /

-0.18 (-0.38%)

Hot Stocks
Driver sends letter to First United Corp shareholders » 08:23
05/26/20
05/26
08:23
05/26/20
08:23
FUNC

First United Corp

$13.75 /

-0.31 (-2.20%)

Driver, one of the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUNC First United Corp
$13.75 /

-0.31 (-2.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.